Streamline Health Solutions

Streamline Health Solutions, Inc. engages in the provision of transformational data-driven solutions for healthcare organizations. Its solutions include Health Information Management (HIM), Coding and CDI, evaluator coding analysis platforms, financial management, and patient care. It also offers audit, custom integration, training, electronic image conversion, and database monitoring services. The company was founded by J. Brian Patsy in October 1989 and is headquartered in Alpharetta, GA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Streamline Health Solutions reports robust Q4 earnings and cost-saving integration

Streamline Health Solutions delivered robust financial results, showcasing strong revenue growth and a healthy balance sheet. The integration of recent acquisitions has led to substantial cost savings, while the company's focus on innovation and service delivery bodes well for future opportunities.

Streamline Health Solutions reports strong Q2 performance and innovation

Streamline Health Solutions delivered a strong performance in Q2 2023, demonstrating resilience in its financials and progress in scaling its technology offerings. The company's strengths lie in its ability to drive SaaS revenue growth, manage operating expenses, and innovate with AI-based tools. While facing challenges in the selling environment, Streamline Health has opportunities to leverage its cash position and technology advancements for future growth.

Streamline Health Solutions reports mixed Q3 results, focuses on SaaS growth and partnerships

Streamline Health Solutions reported mixed financial results for Q3 2023, with revenue growth in SaaS but a significant net loss due to a noncash impairment charge. The company is prioritizing improving its liquidity position and focusing on upsell and cross-sell opportunities. Progress is being made in relationships with key partners, and there is an opportunity for significant SaaS ARR growth in the future.

Streamline Health reports robust growth and innovation amidst financial challenges

Streamline Health Solutions demonstrated strong financial growth and operational efficiency in Q4 2022, driven by robust SaaS revenue and strategic initiatives.
While facing financial challenges and the goal of achieving breakeven EBITDA, the company's focus on innovation, client expansion, and revenue optimization positions it for future success.
With a solid foundation, a focus on impactful clients, and a commitment to product enhancement, Streamline Health has opportunities to capitalize on market demand and drive sustainable growth.

Streamline Health Solutions reports Q1 growth amidst breakeven targets

Streamline Health Solutions showed resilience with revenue growth and cost management efforts.
The company faces liquidity challenges but aims to achieve breakeven adjusted EBITDA by Q3 2023.
Opportunities lie in increasing SaaS revenue and leveraging integrated operations for growth.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Reviews how automated pre-bill coding analysis helps pro viders improve financial performance

KLAS Research's First Look Report Gives High Marks To Streamline Health's eValuator™ Pre-Bill Coding Analysis Technology

Atlanta, GA, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc. (Nasdaq: STRM), provider of the eValuator™ Revenue Integrity Program to help healthcare providers proactively address revenue leakage and improve financial performance, has been invited to participate in the 12 th Annual Craig-Hallum Alpha Select Conference, which is being held virtually on Tuesday, November 16, 2021.

Streamline Health® To Participate in 12th Annual Craig-Hallum Alpha Select Conference on November 16, 2021

Streamline Health® to Present at Fall Harvest – Best Ideas From the Buy-Side

Streamline Health Solutions, Inc. (STRM) CEO Tee Green on Q2 2021 Results - Earnings Call Transcript

Second quarter 2021 Revenues of $2.9 million; ($0.1 million) Net Loss; ($0.8 million) Adjusted EBITDA

Streamline Health® Reports Second Quarter 2021 Financial Results

Automated Coding Analysis for Inpatient and Outpatient Care

North Carolina-Based Medical Center Signs New Contract for Streamline Health® eValuator™

ATLANTA, GA, Aug. 26, 2021 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc. (NASDAQ: STRM), provider of the eValuator™ Revenue Integrity Program to help healthcare providers proactively address revenue leakage and compliance exposure, today announced that it will release its financial results for the three months ended July 31, 2021 on Wednesday, September 8, 2021 after the close of the financial markets.

Streamline Health® To Report Second Quarter 2021 Financial Performance and Provide Corporate Update

SAN FRANCISCO, Aug. 24, 2021 /PRNewswire/ -- Capital Clarity announced the close of Streamline Health Solutions, Inc.'s (NASDAQ: STRM) ("Streamline") acquisition of Avelead Consulting, LLC ("Avelead"), a recognized leader in providing solutions and services to improve revenue integrity for healthcare providers nationwide. Terms of the deal include closing cash and stock consideration valued at $20 million, subject to customary post-closing adjustments for working capital, cash, debt and transaction expenses, and a performance-based earnout with an estimated value of $15 million.

Capital Clarity Advises Streamline Health in its Acquisition of Avelead

Projected Accretive Acquisition To E xpand Capabilities To I mprove Healthcare Providers' Revenue Cycle Performance

Streamline Health® Expands SaaS Portfolio Through Acquisition of Avelead

Automated Coding Analysis for Inpatient Care

Missouri Hospital Signs New Contract for Streamline Health® eValuator™

Large Midwestern Health System Signs New Contract for Streamline Health® eValuator™

Atlanta, GA, June 16, 2021 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc. (NASDAQ: STRM), provider of the eValuator™ Revenue Integrity Program to help healthcare providers proactively address revenue leakage and compliance exposure, today announced it received notice from Western Alliance Bank, the lender of the Company's $2,300,600 Paycheck Protection Program (“PPP”) loan, that the U.S. Small Business Administration (“SBA”) approved the forgiveness of the PPP loan.

Streamline Health® Receives Forgiveness of Paycheck Protection Program Loan

Streamline Health Solutions, Inc. (STRM) CEO Tee Green on Q1 2021 Results - Earnings Call Transcript

Shares of Streamline Health Solns (NASDAQ:STRM) were flat after the company reported Q1 results. Quarterly Results Earnings per share decreased 133.33% over the past year to ($0.07), which missed the estimate of ($0.05).

Streamline Health Solns: Q1 Earnings Insights

First quarter 2021 Revenues of $3.0 million; ($2.1 million) Net Loss; ($0.7 million) Adjusted EBITDA

Streamline Health® Reports First Quarter 2021 Financial Results

Earnings and EPS are useful metrics of profitability. Total earnings also known as net income is equal to total revenue minus total expenses.

Earnings Preview for Streamline Health Solns

ATLANTA, GA, June 02, 2021 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc. (NASDAQ:STRM), provider of the eValuator™ Revenue Integrity Program to help healthcare providers proactively address revenue leakage and compliance exposure, today announced that it will release its financial results for the three months ended April 30, 2021 on Tuesday, June 8, 2021 after the close of the financial markets.

Streamline Health® To Report First Quarter 2021 Financial Performance June 8, 2021

Streamline Health Solutions, Inc. (STRM) CEO Tee Green on Q4 2020 Results - Earnings Call Transcript

Fiscal 2020 Revenues of $11.3 million; $0.3 million Net Income; Adjusted EBITDA ($1.9 million)

Streamline Health® Reports Fourth Quarter and Fiscal Year 2020 Financial Results

ATLANTA, GA, April 15, 2021 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc. (NASDAQ: STRM), provider of the eValuator™ Revenue Integrity Program to help healthcare providers proactively address revenue leakage and compliance exposure, today announced that it will release its financial results for the three and twelve month periods ended January 31, 2021 on Wednesday, April 21, 2021 after the close of the financial markets.

Streamline Health® To Report Fourth Quarter and Fiscal Year 2020 Financial Performance on April 21, 2021

﻿﻿Automated Coding Analysis for Inpatient and Outpatient Care

Midwestern Medical Center Signs New Contract for Streamline Health® eValuator™

The stock price of Streamline Health Solutions, Inc. (NASDAQ: STRM) has increased by over 20% pre-market. This is why it happened.

STRM Stock Price Increases Over 20% Pre-Market: Why It Happened

Atlanta, GA, March 02, 2021 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc. (NASDAQ: STRM), provider of the eValuator™ Revenue Integrity Program to help healthcare providers proactively address revenue leakage and compliance exposure, today announced it has expanded its existing relationship with Bridge Bank on its credit facility.

Streamline Health® Expands Credit Facility with Bridge Bank

ATLANTA, GA, Feb. 26, 2021 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc. (NASDAQ: STRM) (“Streamline Health”), provider of the eValuator™ Revenue Integrity Program to help healthcare providers proactively address revenue leakage and compliance, today announced the pricing of an underwritten public offering of 8,750,000 shares of its common stock at a purchase price to the public of $1.60 per share. Additionally, in connection with the offering, Streamline Health granted the underwriter a 30-day option to purchase up to an additional 1,312,500 shares of its common stock on the same terms and conditions. All of the securities in the offering are being sold by Streamline Health. The offering is expected to close on or about March 2, 2021, subject to the satisfaction of customary closing conditions.

Streamline Health Announces Pricing of Upsized $14 Million Public Offering of Common Stock

ATLANTA, GA, Feb. 25, 2021 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc. (NASDAQ: STRM) (“Streamline Health” or the “Company”), provider of the eValuator™ Revenue Integrity Program to help healthcare providers proactively address revenue leakage and compliance, today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. The proposed offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. Streamline Health also intends to grant the underwriter a 30-day option to purchase up to an additional 15% of the shares of common stock sold in the offering to cover over-allotments, if any. All of the securities in the proposed offering are to be sold by Streamline Health.

News for Streamline Health Solutions Stock (STRM)